BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 3929876)

  • 1. Efficacy of feverfew as prophylactic treatment of migraine.
    Johnson ES; Kadam NP; Hylands DM; Hylands PJ
    Br Med J (Clin Res Ed); 1985 Aug; 291(6495):569-73. PubMed ID: 3929876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised double-blind placebo-controlled trial of feverfew in migraine prevention.
    Murphy JJ; Heptinstall S; Mitchell JR
    Lancet; 1988 Jul; 2(8604):189-92. PubMed ID: 2899663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study.
    Pfaffenrath V; Diener HC; Fischer M; Friede M; Henneicke-von Zepelin HH;
    Cephalalgia; 2002 Sep; 22(7):523-32. PubMed ID: 12230594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feverfew as a preventive treatment for migraine: a systematic review.
    Vogler BK; Pittler MH; Ernst E
    Cephalalgia; 1998 Dec; 18(10):704-8. PubMed ID: 9950629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal aberrations and sister chromatid exchanges in lymphocytes and urine mutagenicity of migraine patients: a comparison of chronic feverfew users and matched non-users.
    Anderson D; Jenkinson PC; Dewdney RS; Blowers SD; Johnson ES; Kadam NP
    Hum Toxicol; 1988 Mar; 7(2):145-52. PubMed ID: 2967795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of feverfew as prophylactic treatment of migraine.
    Waller PC; Ramsay LE
    Br Med J (Clin Res Ed); 1985 Oct; 291(6502):1128. PubMed ID: 3931825
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of feverfew as prophylactic treatment of migraine.
    Wind J; Punt J
    Br Med J (Clin Res Ed); 1985 Nov; 291(6507):1508. PubMed ID: 3933730
    [No Abstract]   [Full Text] [Related]  

  • 8. A double-blind placebo-controlled pilot study of sublingual feverfew and ginger (LipiGesic™ M) in the treatment of migraine.
    Cady RK; Goldstein J; Nett R; Mitchell R; Beach ME; Browning R
    Headache; 2011; 51(7):1078-86. PubMed ID: 21631494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feverfew for preventing migraine.
    Pittler MH; Vogler BK; Ernst E
    Cochrane Database Syst Rev; 2000; (3):CD002286. PubMed ID: 10908545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and safety of feverfew (Tanacetum parthenium L.): an update of a systematic review.
    Ernst E; Pittler MH
    Public Health Nutr; 2000 Dec; 3(4A):509-14. PubMed ID: 11276299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial.
    Maizels M; Blumenfeld A; Burchette R
    Headache; 2004 Oct; 44(9):885-90. PubMed ID: 15447697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tanacetum parthenium and Salix alba (Mig-RL) combination in migraine prophylaxis: a prospective, open-label study.
    Shrivastava R; Pechadre JC; John GW
    Clin Drug Investig; 2006; 26(5):287-96. PubMed ID: 17163262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feverfew for preventing migraine.
    Pittler MH; Ernst E
    Cochrane Database Syst Rev; 2004; (1):CD002286. PubMed ID: 14973986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Feverfew as a prophylactic treatment of migraine].
    Prusiński A; Durko A; Niczyporuk-Turek A
    Neurol Neurochir Pol; 1999; 33 Suppl 5():89-95. PubMed ID: 10719691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress in the medicinal chemistry of the herb feverfew.
    Groenewegen WA; Knight DW; Heptinstall S
    Prog Med Chem; 1992; 29():217-38. PubMed ID: 1475370
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study.
    Diener HC; Pfaffenrath V; Schnitker J; Friede M; Henneicke-von Zepelin HH
    Cephalalgia; 2005 Nov; 25(11):1031-41. PubMed ID: 16232154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feverfew in rheumatoid arthritis: a double blind, placebo controlled study.
    Pattrick M; Heptinstall S; Doherty M
    Ann Rheum Dis; 1989 Jul; 48(7):547-9. PubMed ID: 2673080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combination of coenzyme Q10, feverfew and magnesium for migraine prophylaxis: a prospective observational study.
    Guilbot A; Bangratz M; Ait Abdellah S; Lucas C
    BMC Complement Altern Med; 2017 Aug; 17(1):433. PubMed ID: 28854909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on the antimigraine action of Feverfew (Tanacetum parthenium (L.) Sch. Bip.)].
    Studzińska-Sroka E; Znajdek-Awizeń P; Gawron-Gzella A
    Wiad Lek; 2013; 66(2 Pt 2):195-9. PubMed ID: 25775817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet aggregation in patients using feverfew for migraine.
    Biggs MJ; Johnson ES; Persaud NP; Ratcliffe DM
    Lancet; 1982 Oct; 2(8301):776. PubMed ID: 6125851
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.